Delivery Order SPE2DB22D3011-SPE2DB25FQ0YD
Award Date
5/20/25
Potential Completion Date
5/21/25
Potential Value
$2.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Boostrix TDAP vaccines in 0.5 mL syringes. The contract has a firm fixed price of $2,554.30 and a completion date of May 28, 2024. The award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award is from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,154.98 fixed-price delivery order is for the BOOSTRIX TDAP Vaccine Syringe 0.5ML, with a completion date of January 7, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $2,592.50 and an ultimate completion date of June 24, 2024. It is a firm fixed-price contract awarded without any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of BOOSTRIX TDAP vaccines in 0.5 mL syringes. The $5,499.04 firm-fixed-price delivery order has an ultimate completion date of August 21, 2024 and does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999 through December 2025 for...
This federal contract award to Amerisourcebergen Drug Corp (AmerisourceBergen) by the Defense Logistics Agency (DLA) is for the delivery of BOOSTRIX TDAP vaccine syringes (0.5mL). The contract, valued at $1,031.16, is a Firm Fixed Price Delivery Order with a completion date of July 16, 2024. The contract is not designated with a set-aside. AmerisourceBergen, a major pharmaceutical distributor and healthcare solutions provider, holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Boostrix TDAP vaccine syringes. The contract has a ceiling value of $9,404.28 and is a firm fixed-price delivery order with a performance period ending on May 21, 2025. The contract is not set aside for any particular business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,682.02 delivery order is for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a period of performance through January 7, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a primary vehicle for providing a comprehensive...
This federal contract award, valued at $3,182.21, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Boostrix TDAP vaccine syringes, 0.5 ml, with a performance period through May 8, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Boostrix TDAP vaccine syringes, valued at $17,024.64 with a completion date of April 9, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,097.72 firm fixed-price delivery order is for the supply of 4,565,469,335 units of the BOOSTRIX TDAP vaccine syringe (0.5ML). This award is not associated with any set-aside designation. The contract has an ultimate completion date of August 16, 2024. Amerisourcebergen has a significant Indefinite Delivery Contract (IDC)...